Professor of Health Policy and Co-Director
Menzies Centre for Health Policy, University of Sydney
Professor Adam Elshaug, M.P.H., Ph.D., is an internationally recognized researcher and policy advisor specializing in the calculation of low-value care (prevalence and costs of) and reducing waste to optimize value in health care. He is Chair and Professor in Health Policy and Co-Director of the Menzies Centre for Health Policy (MCHP) at The University of Sydney, Australia. Professor Elshaug is a Ministerial appointee to the (Australian) Medicare Benefits Schedule (MBS) Review Taskforce. This is undertaking a 4-year process to review Australia’s entire Medicare fee-for-service system utilising HTA principles and processes. In October 2017 Professor Elshaug was appointed to the Board of the NSW Bureau of Health Information (BHI), an arms-length government agency that publicly reports on the performance of all public hospitals. He is a Chief Investigator within the Wiser Healthcare Collaborative: http://wiserhealthcare.org.au/ and a Chief Investigator and Lead of the Safety, Quality and Value stream of the recently awarded USD$100 million ‘Digital Health Cooperative Research Centre’ (DHCRC). Professor Elshaug is Senior Fellow with the Lown Institute in Boston, USA. Professor Elshaug was a 2010-11 Commonwealth Fund Harkness Fellow based at the US Agency for Healthcare Research and Quality (AHRQ). From mid-2011 to mid-2013, he then served as NHMRC Sidney Sax Fellow in Harvard Medical School’s Department of Health Care Policy. In parallel, he became The Commonwealth Fund's Inaugural Visiting Fellow for 2012-13 in New York City. He is recipient of numerous research awards and over 150 invitations to address conferences, government, academic, insurance and health technology assessment groups internationally. He has published over 120 technical reports and peer review articles with first-author publications in journals such as The Lancet, New England Journal of Medicine, BMJ, JAMA, Medical Journal of Australia, BMJ Quality & Safety. Professor Elshaug was Co-Lead of 2017 ‘Right Care’ Series of papers in The Lancet.
|2 FEB, 2019||10:30-12-30 hrs.||PS 2.5||Best Buys, Wasted Buys and Controversies in NCD prevention|